Details of the Drug Reposition

General Information of This Drug (ID: DMNGIX3)

Drug Name
RG6287   DMNGIX3
Drug Type
Fusion protein

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Acute graft versus host disease DIS8KLVM 4B24.0 Phase 1 [1]
Inflammatory bowel disease DISGN23E DD72 Phase 1 [2]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of Roche
2 Clinical pipeline report, company report or official report of Genentch